UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress Aug 29, 2025 01:15AM
UCB enters into collaboration with Roche to develop antibody treatment for people living with Alzheimer's Disease Jul 29, 2020 07:00AM
UCB Half Year Report 2020 Jul 27, 2020 07:00AM
UCB Acquires Engage Therapeutics: Staccato® Alprazolam - A potential Solution for Acute On-demand Seizure Management for People Living With Epilepsy Jun 5, 2020 07:00AM
UCB Presents Final Results from Phase II Study of Rozanolixizumab in Primary Immune Thrombocytopenia (ITP) at 2019 ASH Annual Meeting Dec 9, 2019 07:45PM